0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Dimenhydrinate - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-31V8085
Home | Market Reports | Health| Pharmacy
Global Dimenhydrinate Market Insights Forecast to 2028
BUY CHAPTERS

Dimenhydrinate - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-31V8085
Report
November 2024
Pages:167
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dimenhydrinate - Market Size

The global market for Dimenhydrinate was estimated to be worth US$ 1738 million in 2023 and is forecast to a readjusted size of US$ 2490.6 million by 2030 with a CAGR of 5.3% during the forecast period 2024-2030

Dimenhydrinate - Market

Dimenhydrinate - Market

Dimenhydrinate, also known as Dramamine or Gravol, is an over-the-counter drug used to prevent nausea, vomiting, and dizziness caused by motion sickness.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dimenhydrinate, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Dimenhydrinate by region & country, by Type, and by Application.
The Dimenhydrinate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dimenhydrinate.
Market Segmentation

Scope of Dimenhydrinate - Market Report

Report Metric Details
Report Name Dimenhydrinate - Market
Forecasted market size in 2030 US$ 2490.6 million
CAGR 5.3%
Forecasted years 2024 - 2030
Segment by Type:
  • Oral
  • Injection
Segment by Application
  • Hospital
  • Drug Store
  • On-line
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bristol-Myers Squibb, Baxter Healthcare, Watson Laboratories, Pfizer, Nexgen Pharma, Goodwill Pharma, Hennig Arzneimittel, Zambon, Apotex, Teva, Mylan, Cinfa, Neuraxpharm Arzneimittel, Gedeon Richter, Medrock Biotech, Strides Pharma, Fresenius, Novartis, Johnson and Johnson, Yoshindo, IFET, Bayer, Nidda Healthcare, Medifarma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Dimenhydrinate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Dimenhydrinate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Dimenhydrinate in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Dimenhydrinate - Market size in 2030?

Ans: The Dimenhydrinate - Market size in 2030 will be US$ 2490.6 million.

Who are the main players in the Dimenhydrinate - Market report?

Ans: The main players in the Dimenhydrinate - Market are Bristol-Myers Squibb, Baxter Healthcare, Watson Laboratories, Pfizer, Nexgen Pharma, Goodwill Pharma, Hennig Arzneimittel, Zambon, Apotex, Teva, Mylan, Cinfa, Neuraxpharm Arzneimittel, Gedeon Richter, Medrock Biotech, Strides Pharma, Fresenius, Novartis, Johnson and Johnson, Yoshindo, IFET, Bayer, Nidda Healthcare, Medifarma

What are the Application segmentation covered in the Dimenhydrinate - Market report?

Ans: The Applications covered in the Dimenhydrinate - Market report are Hospital, Drug Store, On-line

What are the Type segmentation covered in the Dimenhydrinate - Market report?

Ans: The Types covered in the Dimenhydrinate - Market report are Oral, Injection

1 Market Overview
1.1 Dimenhydrinate Product Introduction
1.2 Global Dimenhydrinate Market Size Forecast
1.2.1 Global Dimenhydrinate Sales Value (2019-2030)
1.2.2 Global Dimenhydrinate Sales Volume (2019-2030)
1.2.3 Global Dimenhydrinate Sales Price (2019-2030)
1.3 Dimenhydrinate Market Trends & Drivers
1.3.1 Dimenhydrinate Industry Trends
1.3.2 Dimenhydrinate Market Drivers & Opportunity
1.3.3 Dimenhydrinate Market Challenges
1.3.4 Dimenhydrinate Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Dimenhydrinate Players Revenue Ranking (2023)
2.2 Global Dimenhydrinate Revenue by Company (2019-2024)
2.3 Global Dimenhydrinate Players Sales Volume Ranking (2023)
2.4 Global Dimenhydrinate Sales Volume by Company Players (2019-2024)
2.5 Global Dimenhydrinate Average Price by Company (2019-2024)
2.6 Key Manufacturers Dimenhydrinate Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Dimenhydrinate Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Dimenhydrinate
2.9 Dimenhydrinate Market Competitive Analysis
2.9.1 Dimenhydrinate Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Dimenhydrinate Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dimenhydrinate as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral
3.1.2 Injection
3.2 Global Dimenhydrinate Sales Value by Type
3.2.1 Global Dimenhydrinate Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Dimenhydrinate Sales Value, by Type (2019-2030)
3.2.3 Global Dimenhydrinate Sales Value, by Type (%) (2019-2030)
3.3 Global Dimenhydrinate Sales Volume by Type
3.3.1 Global Dimenhydrinate Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Dimenhydrinate Sales Volume, by Type (2019-2030)
3.3.3 Global Dimenhydrinate Sales Volume, by Type (%) (2019-2030)
3.4 Global Dimenhydrinate Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Drug Store
4.1.3 On-line
4.2 Global Dimenhydrinate Sales Value by Application
4.2.1 Global Dimenhydrinate Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Dimenhydrinate Sales Value, by Application (2019-2030)
4.2.3 Global Dimenhydrinate Sales Value, by Application (%) (2019-2030)
4.3 Global Dimenhydrinate Sales Volume by Application
4.3.1 Global Dimenhydrinate Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Dimenhydrinate Sales Volume, by Application (2019-2030)
4.3.3 Global Dimenhydrinate Sales Volume, by Application (%) (2019-2030)
4.4 Global Dimenhydrinate Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Dimenhydrinate Sales Value by Region
5.1.1 Global Dimenhydrinate Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Dimenhydrinate Sales Value by Region (2019-2024)
5.1.3 Global Dimenhydrinate Sales Value by Region (2025-2030)
5.1.4 Global Dimenhydrinate Sales Value by Region (%), (2019-2030)
5.2 Global Dimenhydrinate Sales Volume by Region
5.2.1 Global Dimenhydrinate Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Dimenhydrinate Sales Volume by Region (2019-2024)
5.2.3 Global Dimenhydrinate Sales Volume by Region (2025-2030)
5.2.4 Global Dimenhydrinate Sales Volume by Region (%), (2019-2030)
5.3 Global Dimenhydrinate Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Dimenhydrinate Sales Value, 2019-2030
5.4.2 North America Dimenhydrinate Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Dimenhydrinate Sales Value, 2019-2030
5.5.2 Europe Dimenhydrinate Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Dimenhydrinate Sales Value, 2019-2030
5.6.2 Asia Pacific Dimenhydrinate Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Dimenhydrinate Sales Value, 2019-2030
5.7.2 South America Dimenhydrinate Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Dimenhydrinate Sales Value, 2019-2030
5.8.2 Middle East & Africa Dimenhydrinate Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Dimenhydrinate Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Dimenhydrinate Sales Value
6.2.1 Key Countries/Regions Dimenhydrinate Sales Value, 2019-2030
6.2.2 Key Countries/Regions Dimenhydrinate Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Dimenhydrinate Sales Value, 2019-2030
6.3.2 United States Dimenhydrinate Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Dimenhydrinate Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Dimenhydrinate Sales Value, 2019-2030
6.4.2 Europe Dimenhydrinate Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Dimenhydrinate Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Dimenhydrinate Sales Value, 2019-2030
6.5.2 China Dimenhydrinate Sales Value by Type (%), 2023 VS 2030
6.5.3 China Dimenhydrinate Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Dimenhydrinate Sales Value, 2019-2030
6.6.2 Japan Dimenhydrinate Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Dimenhydrinate Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Dimenhydrinate Sales Value, 2019-2030
6.7.2 South Korea Dimenhydrinate Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Dimenhydrinate Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Dimenhydrinate Sales Value, 2019-2030
6.8.2 Southeast Asia Dimenhydrinate Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Dimenhydrinate Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Dimenhydrinate Sales Value, 2019-2030
6.9.2 India Dimenhydrinate Sales Value by Type (%), 2023 VS 2030
6.9.3 India Dimenhydrinate Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Company Information
7.1.2 Bristol-Myers Squibb Introduction and Business Overview
7.1.3 Bristol-Myers Squibb Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Bristol-Myers Squibb Dimenhydrinate Product Offerings
7.1.5 Bristol-Myers Squibb Recent Development
7.2 Baxter Healthcare
7.2.1 Baxter Healthcare Company Information
7.2.2 Baxter Healthcare Introduction and Business Overview
7.2.3 Baxter Healthcare Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Baxter Healthcare Dimenhydrinate Product Offerings
7.2.5 Baxter Healthcare Recent Development
7.3 Watson Laboratories
7.3.1 Watson Laboratories Company Information
7.3.2 Watson Laboratories Introduction and Business Overview
7.3.3 Watson Laboratories Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Watson Laboratories Dimenhydrinate Product Offerings
7.3.5 Watson Laboratories Recent Development
7.4 Pfizer
7.4.1 Pfizer Company Information
7.4.2 Pfizer Introduction and Business Overview
7.4.3 Pfizer Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Pfizer Dimenhydrinate Product Offerings
7.4.5 Pfizer Recent Development
7.5 Nexgen Pharma
7.5.1 Nexgen Pharma Company Information
7.5.2 Nexgen Pharma Introduction and Business Overview
7.5.3 Nexgen Pharma Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Nexgen Pharma Dimenhydrinate Product Offerings
7.5.5 Nexgen Pharma Recent Development
7.6 Goodwill Pharma
7.6.1 Goodwill Pharma Company Information
7.6.2 Goodwill Pharma Introduction and Business Overview
7.6.3 Goodwill Pharma Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Goodwill Pharma Dimenhydrinate Product Offerings
7.6.5 Goodwill Pharma Recent Development
7.7 Hennig Arzneimittel
7.7.1 Hennig Arzneimittel Company Information
7.7.2 Hennig Arzneimittel Introduction and Business Overview
7.7.3 Hennig Arzneimittel Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Hennig Arzneimittel Dimenhydrinate Product Offerings
7.7.5 Hennig Arzneimittel Recent Development
7.8 Zambon
7.8.1 Zambon Company Information
7.8.2 Zambon Introduction and Business Overview
7.8.3 Zambon Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Zambon Dimenhydrinate Product Offerings
7.8.5 Zambon Recent Development
7.9 Apotex
7.9.1 Apotex Company Information
7.9.2 Apotex Introduction and Business Overview
7.9.3 Apotex Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Apotex Dimenhydrinate Product Offerings
7.9.5 Apotex Recent Development
7.10 Teva
7.10.1 Teva Company Information
7.10.2 Teva Introduction and Business Overview
7.10.3 Teva Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Teva Dimenhydrinate Product Offerings
7.10.5 Teva Recent Development
7.11 Mylan
7.11.1 Mylan Company Information
7.11.2 Mylan Introduction and Business Overview
7.11.3 Mylan Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Mylan Dimenhydrinate Product Offerings
7.11.5 Mylan Recent Development
7.12 Cinfa
7.12.1 Cinfa Company Information
7.12.2 Cinfa Introduction and Business Overview
7.12.3 Cinfa Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Cinfa Dimenhydrinate Product Offerings
7.12.5 Cinfa Recent Development
7.13 Neuraxpharm Arzneimittel
7.13.1 Neuraxpharm Arzneimittel Company Information
7.13.2 Neuraxpharm Arzneimittel Introduction and Business Overview
7.13.3 Neuraxpharm Arzneimittel Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Neuraxpharm Arzneimittel Dimenhydrinate Product Offerings
7.13.5 Neuraxpharm Arzneimittel Recent Development
7.14 Gedeon Richter
7.14.1 Gedeon Richter Company Information
7.14.2 Gedeon Richter Introduction and Business Overview
7.14.3 Gedeon Richter Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Gedeon Richter Dimenhydrinate Product Offerings
7.14.5 Gedeon Richter Recent Development
7.15 Medrock Biotech
7.15.1 Medrock Biotech Company Information
7.15.2 Medrock Biotech Introduction and Business Overview
7.15.3 Medrock Biotech Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Medrock Biotech Dimenhydrinate Product Offerings
7.15.5 Medrock Biotech Recent Development
7.16 Strides Pharma
7.16.1 Strides Pharma Company Information
7.16.2 Strides Pharma Introduction and Business Overview
7.16.3 Strides Pharma Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Strides Pharma Dimenhydrinate Product Offerings
7.16.5 Strides Pharma Recent Development
7.17 Fresenius
7.17.1 Fresenius Company Information
7.17.2 Fresenius Introduction and Business Overview
7.17.3 Fresenius Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Fresenius Dimenhydrinate Product Offerings
7.17.5 Fresenius Recent Development
7.18 Novartis
7.18.1 Novartis Company Information
7.18.2 Novartis Introduction and Business Overview
7.18.3 Novartis Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Novartis Dimenhydrinate Product Offerings
7.18.5 Novartis Recent Development
7.19 Johnson and Johnson
7.19.1 Johnson and Johnson Company Information
7.19.2 Johnson and Johnson Introduction and Business Overview
7.19.3 Johnson and Johnson Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Johnson and Johnson Dimenhydrinate Product Offerings
7.19.5 Johnson and Johnson Recent Development
7.20 Yoshindo
7.20.1 Yoshindo Company Information
7.20.2 Yoshindo Introduction and Business Overview
7.20.3 Yoshindo Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Yoshindo Dimenhydrinate Product Offerings
7.20.5 Yoshindo Recent Development
7.21 IFET
7.21.1 IFET Company Information
7.21.2 IFET Introduction and Business Overview
7.21.3 IFET Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.21.4 IFET Dimenhydrinate Product Offerings
7.21.5 IFET Recent Development
7.22 Bayer
7.22.1 Bayer Company Information
7.22.2 Bayer Introduction and Business Overview
7.22.3 Bayer Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.22.4 Bayer Dimenhydrinate Product Offerings
7.22.5 Bayer Recent Development
7.23 Nidda Healthcare
7.23.1 Nidda Healthcare Company Information
7.23.2 Nidda Healthcare Introduction and Business Overview
7.23.3 Nidda Healthcare Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.23.4 Nidda Healthcare Dimenhydrinate Product Offerings
7.23.5 Nidda Healthcare Recent Development
7.24 Medifarma
7.24.1 Medifarma Company Information
7.24.2 Medifarma Introduction and Business Overview
7.24.3 Medifarma Dimenhydrinate Sales, Revenue and Gross Margin (2019-2024)
7.24.4 Medifarma Dimenhydrinate Product Offerings
7.24.5 Medifarma Recent Development
8 Industry Chain Analysis
8.1 Dimenhydrinate Industrial Chain
8.2 Dimenhydrinate Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Dimenhydrinate Sales Model
8.5.2 Sales Channel
8.5.3 Dimenhydrinate Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Dimenhydrinate Market Trends
    Table 2. Dimenhydrinate Market Drivers & Opportunity
    Table 3. Dimenhydrinate Market Challenges
    Table 4. Dimenhydrinate Market Restraints
    Table 5. Global Dimenhydrinate Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Dimenhydrinate Revenue Market Share by Company (2019-2024)
    Table 7. Global Dimenhydrinate Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Dimenhydrinate Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Dimenhydrinate Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Dimenhydrinate Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Dimenhydrinate Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Dimenhydrinate
    Table 13. Global Dimenhydrinate Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dimenhydrinate as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Dimenhydrinate Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Dimenhydrinate Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Dimenhydrinate Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Dimenhydrinate Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Dimenhydrinate Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Dimenhydrinate Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Dimenhydrinate Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Dimenhydrinate Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Dimenhydrinate Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Dimenhydrinate Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Dimenhydrinate Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Dimenhydrinate Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Dimenhydrinate Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Dimenhydrinate Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Dimenhydrinate Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Dimenhydrinate Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Dimenhydrinate Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Dimenhydrinate Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Dimenhydrinate Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Dimenhydrinate Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Dimenhydrinate Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Dimenhydrinate Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Dimenhydrinate Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Dimenhydrinate Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Dimenhydrinate Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Dimenhydrinate Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Dimenhydrinate Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Dimenhydrinate Sales Value by Region (2019-2024) & (%)
    Table 44. Global Dimenhydrinate Sales Value by Region (2025-2030) & (%)
    Table 45. Global Dimenhydrinate Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Dimenhydrinate Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Dimenhydrinate Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Dimenhydrinate Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Dimenhydrinate Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Dimenhydrinate Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Dimenhydrinate Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Dimenhydrinate Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Dimenhydrinate Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Dimenhydrinate Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Dimenhydrinate Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Dimenhydrinate Sales Volume, (2025-2030) & (K Units)
    Table 57. Bristol-Myers Squibb Company Information
    Table 58. Bristol-Myers Squibb Introduction and Business Overview
    Table 59. Bristol-Myers Squibb Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Bristol-Myers Squibb Dimenhydrinate Product Offerings
    Table 61. Bristol-Myers Squibb Recent Development
    Table 62. Baxter Healthcare Company Information
    Table 63. Baxter Healthcare Introduction and Business Overview
    Table 64. Baxter Healthcare Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Baxter Healthcare Dimenhydrinate Product Offerings
    Table 66. Baxter Healthcare Recent Development
    Table 67. Watson Laboratories Company Information
    Table 68. Watson Laboratories Introduction and Business Overview
    Table 69. Watson Laboratories Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Watson Laboratories Dimenhydrinate Product Offerings
    Table 71. Watson Laboratories Recent Development
    Table 72. Pfizer Company Information
    Table 73. Pfizer Introduction and Business Overview
    Table 74. Pfizer Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Pfizer Dimenhydrinate Product Offerings
    Table 76. Pfizer Recent Development
    Table 77. Nexgen Pharma Company Information
    Table 78. Nexgen Pharma Introduction and Business Overview
    Table 79. Nexgen Pharma Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Nexgen Pharma Dimenhydrinate Product Offerings
    Table 81. Nexgen Pharma Recent Development
    Table 82. Goodwill Pharma Company Information
    Table 83. Goodwill Pharma Introduction and Business Overview
    Table 84. Goodwill Pharma Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Goodwill Pharma Dimenhydrinate Product Offerings
    Table 86. Goodwill Pharma Recent Development
    Table 87. Hennig Arzneimittel Company Information
    Table 88. Hennig Arzneimittel Introduction and Business Overview
    Table 89. Hennig Arzneimittel Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Hennig Arzneimittel Dimenhydrinate Product Offerings
    Table 91. Hennig Arzneimittel Recent Development
    Table 92. Zambon Company Information
    Table 93. Zambon Introduction and Business Overview
    Table 94. Zambon Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Zambon Dimenhydrinate Product Offerings
    Table 96. Zambon Recent Development
    Table 97. Apotex Company Information
    Table 98. Apotex Introduction and Business Overview
    Table 99. Apotex Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Apotex Dimenhydrinate Product Offerings
    Table 101. Apotex Recent Development
    Table 102. Teva Company Information
    Table 103. Teva Introduction and Business Overview
    Table 104. Teva Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Teva Dimenhydrinate Product Offerings
    Table 106. Teva Recent Development
    Table 107. Mylan Company Information
    Table 108. Mylan Introduction and Business Overview
    Table 109. Mylan Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Mylan Dimenhydrinate Product Offerings
    Table 111. Mylan Recent Development
    Table 112. Cinfa Company Information
    Table 113. Cinfa Introduction and Business Overview
    Table 114. Cinfa Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Cinfa Dimenhydrinate Product Offerings
    Table 116. Cinfa Recent Development
    Table 117. Neuraxpharm Arzneimittel Company Information
    Table 118. Neuraxpharm Arzneimittel Introduction and Business Overview
    Table 119. Neuraxpharm Arzneimittel Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Neuraxpharm Arzneimittel Dimenhydrinate Product Offerings
    Table 121. Neuraxpharm Arzneimittel Recent Development
    Table 122. Gedeon Richter Company Information
    Table 123. Gedeon Richter Introduction and Business Overview
    Table 124. Gedeon Richter Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Gedeon Richter Dimenhydrinate Product Offerings
    Table 126. Gedeon Richter Recent Development
    Table 127. Medrock Biotech Company Information
    Table 128. Medrock Biotech Introduction and Business Overview
    Table 129. Medrock Biotech Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Medrock Biotech Dimenhydrinate Product Offerings
    Table 131. Medrock Biotech Recent Development
    Table 132. Strides Pharma Company Information
    Table 133. Strides Pharma Introduction and Business Overview
    Table 134. Strides Pharma Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Strides Pharma Dimenhydrinate Product Offerings
    Table 136. Strides Pharma Recent Development
    Table 137. Fresenius Company Information
    Table 138. Fresenius Introduction and Business Overview
    Table 139. Fresenius Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Fresenius Dimenhydrinate Product Offerings
    Table 141. Fresenius Recent Development
    Table 142. Novartis Company Information
    Table 143. Novartis Introduction and Business Overview
    Table 144. Novartis Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. Novartis Dimenhydrinate Product Offerings
    Table 146. Novartis Recent Development
    Table 147. Johnson and Johnson Company Information
    Table 148. Johnson and Johnson Introduction and Business Overview
    Table 149. Johnson and Johnson Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 150. Johnson and Johnson Dimenhydrinate Product Offerings
    Table 151. Johnson and Johnson Recent Development
    Table 152. Yoshindo Company Information
    Table 153. Yoshindo Introduction and Business Overview
    Table 154. Yoshindo Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 155. Yoshindo Dimenhydrinate Product Offerings
    Table 156. Yoshindo Recent Development
    Table 157. IFET Company Information
    Table 158. IFET Introduction and Business Overview
    Table 159. IFET Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 160. IFET Dimenhydrinate Product Offerings
    Table 161. IFET Recent Development
    Table 162. Bayer Company Information
    Table 163. Bayer Introduction and Business Overview
    Table 164. Bayer Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 165. Bayer Dimenhydrinate Product Offerings
    Table 166. Bayer Recent Development
    Table 167. Nidda Healthcare Company Information
    Table 168. Nidda Healthcare Introduction and Business Overview
    Table 169. Nidda Healthcare Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 170. Nidda Healthcare Dimenhydrinate Product Offerings
    Table 171. Nidda Healthcare Recent Development
    Table 172. Medifarma Company Information
    Table 173. Medifarma Introduction and Business Overview
    Table 174. Medifarma Dimenhydrinate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 175. Medifarma Dimenhydrinate Product Offerings
    Table 176. Medifarma Recent Development
    Table 177. Key Raw Materials Lists
    Table 178. Raw Materials Key Suppliers Lists
    Table 179. Dimenhydrinate Downstream Customers
    Table 180. Dimenhydrinate Distributors List
    Table 181. Research Programs/Design for This Report
    Table 182. Key Data Information from Secondary Sources
    Table 183. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dimenhydrinate Product Picture
    Figure 2. Global Dimenhydrinate Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Dimenhydrinate Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Dimenhydrinate Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Dimenhydrinate Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Dimenhydrinate Report Years Considered
    Figure 7. Global Dimenhydrinate Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Dimenhydrinate Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Dimenhydrinate Revenue in 2023
    Figure 10. Dimenhydrinate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Oral Picture
    Figure 12. Injection Picture
    Figure 13. Global Dimenhydrinate Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Dimenhydrinate Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Dimenhydrinate Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Dimenhydrinate Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Dimenhydrinate Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Hospital
    Figure 19. Product Picture of Drug Store
    Figure 20. Product Picture of On-line
    Figure 21. Global Dimenhydrinate Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Dimenhydrinate Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Dimenhydrinate Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global Dimenhydrinate Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Dimenhydrinate Price by Application (2019-2030) & (US$/Unit)
    Figure 26. North America Dimenhydrinate Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Dimenhydrinate Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Dimenhydrinate Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Dimenhydrinate Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Dimenhydrinate Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Dimenhydrinate Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Dimenhydrinate Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Dimenhydrinate Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Dimenhydrinate Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Dimenhydrinate Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Dimenhydrinate Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Dimenhydrinate Sales Volume (%), (2019-2030)
    Figure 38. United States Dimenhydrinate Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Dimenhydrinate Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Dimenhydrinate Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Dimenhydrinate Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Dimenhydrinate Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Dimenhydrinate Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Dimenhydrinate Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Dimenhydrinate Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Dimenhydrinate Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Dimenhydrinate Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Dimenhydrinate Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Dimenhydrinate Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Dimenhydrinate Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Dimenhydrinate Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Dimenhydrinate Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Dimenhydrinate Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Dimenhydrinate Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Dimenhydrinate Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Dimenhydrinate Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Dimenhydrinate Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Dimenhydrinate Sales Value by Application (%), 2023 VS 2030
    Figure 59. Dimenhydrinate Industrial Chain
    Figure 60. Dimenhydrinate Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global RANKL Inhibitors Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-35Z18485
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Morphine Test Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-28M18423
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Compound Antibacterial Agent for Animal - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-38V14855
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Antipyretic Stickers Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-22E8302
Thu Dec 12 00:00:00 UTC 2024

Add to Cart